COVID-19 state of vaccine confidence insights report: mpox outbreak special report

Details

• Corporate Authors:
  Centers for Disease Control & Prevention (U.S.). COVID-19 Response, Vaccine Task Force. Vaccine Confidence & Demand Team. Insights Unit.
• Description:
  Date Range: November 15, 2022 - February 25, 2023
  
  Major themes identified from social media, news, and other sources that may impact vaccine confidence:
  
  • Consumers and social media users in the LGBTQ+ community are taking proper precautions to prevent mpox (formerly known as monkeypox), including getting vaccinated with JYNNEOS vaccine. While the ACAM2000 vaccine has rarely, if ever, been used in the current mpox outbreak, some are concerned about its side effects.
  
  • Consumers and social media users are concerned about poor access to vaccines in Black and Hispanic/Latino communities.
  
  • Some social media users are confused about the name change from monkeypox to mpox and believe it is part of an agenda to push more vaccines.
  
  • Activism and engagement from the LGBTQ+ community has contributed to an increase in mpox vaccine confidence and uptake.
  
  CS000000-A | 5/18/23
  
  SoVC-MPOX-052223.pdf
  
  
• Subjects:
  Mpox (monkeypox)/prevention & Control Smallpox Vaccine Vaccination
• Series:
  COVID-19 State of Vaccine Confidence Insights Report   ; Vaccinate with Confidence  
• Document Type:
  Text
• Genre:
  Newsletter
• Pages in Document:
  18 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:1a5bfc3b06d88c636aa4cfadf748fd19f5b2d989d38200445e77369b61d58ff22abe2f184009862c3d30d5cad7c17a572c312d9014201ebc6b5e5c33e62240d4
• Download URL:
  https://stacks.cdc.gov/view/cdc/128722/cdc_128722_DS1.pdf
• File Type:
  [PDF - 1.24 MB ]